Mei Bai

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: University of Massachusetts Dartmouth (2025); Central South University (2012–2017); Xizang Minzu University (2018–2021); University of Missouri–St. Louis (2018); University of Arkansas Medical Center (2025); Yale University (2013–2017); Mudanjiang Medical University (2012); Second Xiangya Hospital of Central South University (2012–2017); Xiangya Hospital Central South University (2012–2017)

17 h-index 50 pubs 1,112 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Mei Bai's research focuses on investigating disease mechanisms and potential therapeutic interventions, particularly in the context of liver injury, intestinal fibrosis, and cancer progression. Bai has published work exploring the direct inhibition of GSDMD by PEITC to reduce hepatocyte pyroptosis and alleviate acute liver injury in mice, as well as the role of natural compound fraxinellone in ameliorating intestinal fibrosis by intervening with HSP47-collagen interaction. Further investigations include the STAT3-mediated activation of lncRNA NR2F1‐AS1 in melanoma progression and the association of Fc receptor-like variants with rheumatoid arthritis risk in the Chinese Han population. Bai also contributed to a systematic review on the psychological response to advanced cancer diagnoses. Scholarship metrics include an h-index of 19, with 76 total publications and 1,393 total citations.

Metrics

h-index: 17
Publications: 50
Citations: 1,112

Selected Publications

Psychological Adaptation to Newly Diagnosed Advanced Cancer (2025)

Advances in Family Practice Nursing DOI OpenAlex
Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial (2025)

Journal of Psychosocial Oncology 2 citations DOI OpenAlex
Psychological Response to the Diagnosis of Advanced Cancer: A Systematic Review (2021)

Annals of Behavioral Medicine 15 citations DOI OpenAlex